Source MS Trust:
Preliminary results announced in a press release (link is external) report that treatment with Tysabri did not slow down the gradual increase in disability experienced by people with secondary progressive MS. Read on.
Preliminary results announced in a press release (link is external) report that treatment with Tysabri did not slow down the gradual increase in disability experienced by people with secondary progressive MS. Read on.